Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Todd Brady Insider Profile
18 Followers
Todd Brady, President & CEO, Director at Aldeyra Therapeutics, holds 1.47M shares in Aldeyra Therapeutics (Ticker: ALDX), holds 153.29K shares in Oncobiologics Inc (Ticker: ONSIU), holds ― shares in Outlook Therapeutics (Ticker: OTLK).
Todd Brady Aldeyra Therapeutics (ALDX)President & CEO, Director
Aldeyra Therapeutics (ALDX)
President & CEO, Director
Ranked #7,664 out of 98,564 Corporate Insiders
Profitable Transactions
7 out of 8 Profitable Transactions
Average Return
+25.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Todd Brady holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 27, 2022 - Jun 27, 2023
Return:+92.70%
The most profitable trade made by Todd Brady
Todd Brady's Trading History
Aldeyra Therapeutics
Mar 12, 2024
President & CEO, Director
Uninformative Sell
580.42K
$5.75M
Oncobiologics Inc
Nov 14, 2016
―
Uninformative Sell
―
$723.52K
Outlook Therapeutics
―
Director
―
―
F-star Therapeutics
Mar 09, 2023
―
Uninformative Sell
106.83K
$0.00
Evoke Pharma
Sep 24, 2014
Director
Informative Buy
22.80K
$1.77K
List of latest transactions for each holding click on a transaction to see Todd Brady's performance on stock
You May Also Like
Todd Brady insider profile FAQ
What is the percentage of profitable transactions made by Todd Brady?
The percentage of profitable transactions made by Todd Brady is 88%.
What is the average return per transaction made by Todd Brady?
The average return per transaction made by Todd Brady is 25.50%.
What stocks does Todd Brady hold?
Todd Brady holds: ALDX, ONSIU, OTLK, FSTX, EVOK stocks.
What was Todd Brady’s latest transaction?
Todd Brady latest transaction was an Uninformative Sell of $580.42K.
What was Todd Brady's most profitable transaction?
Todd Brady’s most profitable transaction was an Informative Buy of ALDX stock on June 27, 2022. The return on the trade was 92.70%.
What is Todd Brady's role in Aldeyra Therapeutics?
Todd Brady's role in Aldeyra Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.